Statistical inference |
DAISY Jerby-Arnon et al. (2014)
|
Gene pairs that overlap across all assumptions. |
☑ |
☑ |
☑ |
|
|
☑ |
Wilcoxon rank sum, followed by Bonferroni correction for multiple hypothesis testing; gene co-expressions were calculated using Spearman correlation |
|
|
1. Survival of the fittest (SoF): Synthetic lethal pairs are co-inactivated for cell death. |
|
|
|
|
|
|
|
|
|
2. Death upon single gene knockdown when another gene is inactive is synthetic lethality. |
|
|
|
|
|
|
|
|
|
3. Synthetic lethal pairs are co-expressed. |
|
|
|
|
|
|
|
|
Srihari et al. Mutual Exclusivity Model (Srihari et al., 2015) |
Gene pairs that are frequently altered in a mutually exclusive manner are defined as synthetic lethal. |
☑ |
☑ |
|
|
|
|
The statistical significance value was obtained by subtracting SL score obtained by hypergeometric test from 1:
|
|
ISLE Lee et al. (2018)
|
Gene pairs that exhibit the following characteristics: |
☑ |
☑ |
☑ |
☑ |
☑ |
|
Statistical significance tests used for the respective assumptions: |
|
|
1. Gene pairs are rarely co-inactivated compared to their individual inactivation frequencies. |
|
|
|
|
|
|
1. Hypergeometric test |
|
|
2. Gene pairs yield better patient survival through their co-inactivation, reducing tumor fitness when co-inactive. |
|
|
|
|
|
|
2. Likelihood ratio test |
|
|
3. Gene pairs tend to co-evolve and thus have high phylogenetic similarity. |
|
|
|
|
|
|
3. No statistical test at this step |
|
|
|
|
|
|
|
|
|
Afterward, Wilcoxon rank sum was used to compare identified SL pairs with drug target response |
|
ASTER Liany et al. (2020a)
|
Gene pair (Genes A and B) that passes the following tests: |
☑ |
☑ |
☑ |
☑ |
|
|
Wilcoxon rank sum, followed by Fisher’s method for combining significance p-values. False discovery rates were determined using the Benjamini–Hochberg method |
|
|
1. For tissue-specific samples with high Gene A copy number, the expression level of Gene A is significantly higher than that of non-cancerous samples of the same tissue type. |
|
|
|
|
|
|
|
|
|
2. For tissue-specific samples with high Gene A copy number, but low Gene B copy number, expression level of Gene B is significantly lower than that of non-cancerous samples of the same tissue type. |
|
|
|
|
|
|
|
|
|
3. Expression levels of Gene A in Test 1 is significantly higher than those of Gene B in Test 2. |
|
|
☑ |
|
|
|
|
|
SLIdR Srivatsa et al. (2019)
|
Synthetic lethal pairs consist of a significantly mutated gene and its interacting genes that yield cell death upon co-occurrence of their aberrations. |
|
☑ |
☑ |
|
|
☑ |
Custom, rank-based statistical test was used where the p-value was obtained from the lower-tail probability |
|
MiSL Sinha et al. (2017)
|
The mutations of synthetic lethal pairs are amplified more frequently and are deleted less frequently while in concordance with their gene expression profiles. |
☑ |
☑ |
☑ |
|
|
|
Fisher’s exact test for evaluating gene-pair behavior dependence, followed by two-tailed unpaired Student’s t-test |
Network-based models |
VIPER Alvarez et al. (2016)
|
A probabilistic framework where tissue-specific gene-expression data are used to identify regulator-target interactions following the activation or repression of a regulator. |
☑ |
|
|
|
|
|
Analytic rank-based enrichment analysis (aREA) statistical analysis is used to discern differential gene activity |
OptiCon (Hu et al., 2019) |
Using gene expression profiles in a regulatory network, optimal control nodes (OCNs) are identified such that they exert maximal control over deregulated pathways, but minimal control over unaffected pathways for a given disease. For SL tasks, OCNs point to potential synthetic lethal pairs |
☑ |
☑ |
|
|
|
|
Wilcoxon rank test and one-sided Kolmogorov-Smirnov test |